Search Orphan Drug Designations and Approvals
-
Generic Name: | ezogabine |
---|---|
Trade Name: | Potiga |
Date Designated: | 06/21/2018 |
Orphan Designation: | Treatment of KCNQ2 epileptic encephalopathy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Marketing Approval Date: | N/A |
Approved Labeled Indication: | |
Exclusivity End Date: | N/A |
Sponsor: |
Xenon Pharmaceuticals, Inc. 200-3650 Gilmore Way Burnaby, British Columbia Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
-